| CTRI Number |
CTRI/2025/07/090225 [Registered on: 04/07/2025] Trial Registered Prospectively |
| Last Modified On: |
03/07/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Physiotherapy (Not Including YOGA) |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
PRP and Physiotherapy for Nerve and Disc Recovery in Lower Back Disc Herniation |
|
Scientific Title of Study
|
Effectiveness of Ultrasound-Guided Platelet-Rich Plasma Combined with Physiotherapy on Disc Morphology and Neurophysiology in L5/S1 Lumbar Disc Herniation |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Rayhan Islam |
| Designation |
Postgraduate student |
| Affiliation |
Jashore University of Science and Technology |
| Address |
Room - 304, Department of Physiotherapy and Rehabilitation, Jashore University of Science and Technology, Jashore-7408, Bangladesh
7408 Other |
| Phone |
8801680310515 |
| Fax |
|
| Email |
rayhanislam.just@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Kazi Md Amran Hossain |
| Designation |
Lecturer |
| Affiliation |
Jashore University of Science and Technology |
| Address |
Room - 302, Department of Physiotherapy and Rehabilitation, Jashore University of Science and Technology, Jashore-7408, Bangladesh
7408 Other |
| Phone |
8801735661492 |
| Fax |
|
| Email |
kma.hossain@just.edu.bd |
|
Details of Contact Person Public Query
|
| Name |
Dr Kazi Md Amran Hossain |
| Designation |
Lecturer |
| Affiliation |
Jashore University of Science and Technology |
| Address |
Room - 302, Department of Physiotherapy and Rehabilitation, Jashore University of Science and Technology, Jashore-7408, Bangladesh
7408 Other |
| Phone |
8801735661492 |
| Fax |
|
| Email |
kma.hossain@just.edu.bd |
|
|
Source of Monetary or Material Support
|
| Department of Physiotherapy and Rehabilitation, Level 2 and 3, Dr. M R Khan Medical Center, Jashore University of Science and Technology, Jashore-7408, Bangladesh |
|
|
Primary Sponsor
|
| Name |
Dr Ehsanur Rahman |
| Address |
Room - 401, Department of Physiotherapy and Rehabilitation, Jashore University of Science and Technology, Jashore-7408, Bangladesh |
| Type of Sponsor |
Other [University] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
Bangladesh |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Md Kabir Hossain |
Dr. M R Khan Medical Center |
Room - 301, Department of Physiotherapy and Rehabilitation, Musculoskeletal Lab, Jashore University of Science and Technology, Jashore-7408, Bangladesh
|
8801778315139
kabir2002pt@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| IRB of Department of Physiotherapy & Rehabilitation, JUST |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: M438||Other specified deforming dorsopathies, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
McKenzie Exercises |
Total duration: 4 weeks.
Participants in this group will receive the same McKenzie exercise protocol without PRP. They will attend 12 supervised sessions over 4 weeks, performing 10 repetitions of directed lumbar movements (extension, flexion, lateral shifts, rotation) and manipulative therapy (10–15 reps using on-off maneuvers for 5–7 minutes). A home exercise program will be performed 5–7 times per day, for 4 weeks, with 10 reps every 2–3 hours throughout 14 waking hours. |
| Intervention |
PRP + McKenzie Exercises |
Total duration: 4 weeks.
This group will receive:
PRP Therapy: A single ultrasound-guided transforaminal epidural injection of 2–3 mL of autologous PRP prepared from 26 mL of venous blood using a double-spin centrifugation method (yielding 2–5× baseline platelet concentration). The injection will be performed under aseptic conditions with a 22-gauge, 8-inch Quincke Chiba needle. After ultrasound confirmation of needle placement, 2–3 mL of PRP mixed with 0.5 mL of normal saline will be injected at the affected disc level.
McKenzie Exercises: Patients will undergo 12 supervised sessions over 4 weeks. Each session includes 10 repetitions of directed movements (extension, flexion, lateral movements, rotation) and 10–15 repetitions of manipulative therapy for 5–7 minutes. A structured home program will be followed 5–7 times daily for 4 weeks, with 10 reps every 2–3 hours during 14 waking hours. |
|
|
Inclusion Criteria
|
| Age From |
25.00 Year(s) |
| Age To |
55.00 Year(s) |
| Gender |
Both |
| Details |
1. Adults aged 25 to 55 years, both sexes.
2. Clinically diagnosed L5 to S1 lumbar disc herniation confirmed by MRI (disc protrusion or bulge, with or without nerve root compression).
3. Chronic low back pain with or without radiating leg pain, consistent with radiculopathy, for more than 6 weeks.
4. Pain intensity of 3 or above on the Visual Analogue Scale (VAS).
5. Inadequate response to prior conservative treatments (e.g., rest, oral medication, or physiotherapy without supervision).
6. Positive Straight Leg Raise test or neurological signs such as sensory change, weakness, or altered reflex.
7. Platelet count within the normal range (150,000 to 400,000 per microliter).
8. Not currently recommended for surgery or prefers non-surgical treatment.
9. Provides written informed consent to participate. |
|
| ExclusionCriteria |
| Details |
1. Calcified disc herniation or hard disc on imaging
2. Cauda equina syndrome (e.g., urinary retention, saddle anesthesia)
3. Other spinal pathologies, including tumors, spinal infections (e.g., tuberculosis), or vertebral fractures
4. Previous lumbar spine surgery at the affected level
5. Uncontrolled diabetes mellitus
6. Pregnancy
7. Contraindications to PRP or exercises: Bleeding disorders (e.g., haemophilia), Current anticoagulant use (except low-dose aspirin), Severe cardiovascular or neuromuscular comorbidities) |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
1. Pain by NPRS and PPTs
2. Disc Morphology by disc height, disc echogenicity, and disc displacement (assessed via MSK-USG)
3. Neurological Recovery by SLR, NCS, and EMG |
Baseline, 1 month, 3 months, and 6 months post-intervention |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Disability by Oswestry Disability Index (ODI) |
Baseline, 1 month, 3 months, and 6 months post-intervention |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="0"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
Date Missing |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
15/07/2025 |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Applicable |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identification.
- What additional supporting information will be shared?
Response - Study Protocol
- Who will be able to view these files?
Response - Anyone
- For what types of analyses will this data be available?
Response - To achieve aims in the approved proposal.
- By what mechanism will data be made available?
Response - Proposals should be directed to [kma.hossain@just.edu.bd].
- For how long will this data be available start date provided 01-02-2026 and end date provided 01-02-2031?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
|
Brief Summary
|
This randomized controlled trial aims to evaluate the effectiveness of ultrasound-guided platelet-rich plasma (PRP) injection combined with McKenzie exercises compared to McKenzie exercises alone in patients with MRI-confirmed L5/S1 lumbar disc herniation. The study will assess improvements in pain, disc morphology, neurological recovery, and functional disability. Sixty patients will be enrolled and allocated into two groups. The hypothesis is that the combined approach of PRP and physiotherapy will produce superior outcomes in terms of structural and neurophysiological recovery compared to physiotherapy alone. |